In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B for Atlas Genetics brings in £2.1mm; closes round at £16.9mm

Executive Summary

Molecular diagnostics company Atlas Genetics has raised £2.1mm ($4.1mm) in a second venture round to returning shareholders South West Ventures Fund, GEIF Ventures, and individual investors from the South West Angel and Investor Network. First-time backers Finance South West Growth Fund and Braveheart Ventures also participated.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies